CLINICAL_TRIALS
trial_result
· 2025-09-03
Clinical Trial Update: Fluorescence Imaging of Carcinoma During Breast Conserving Surgery [Phase 3]
Summary
Phase 3 trial evaluating fluorescence imaging of carcinoma during breast-conserving surgery was terminated; results have been posted in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: SBI ALApharma Canada, Inc. | Conditions: Breast Neoplasm Female, Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2025-09-03